Sponsored By:
Presented By:

Pain targeting mechanisms

The demand for new therapeutic strategies for pain is high because established drugs have major limitations, including lack of efficacy for conditions such as neuropathic pain and the potential for abuse for opioids. In this webcast, several companies that are working to target unmet needs in pain management will present their developments, which include analgesics with novel mechanisms of action, opioids with reduced potential for abuse and medical devices.

The webcast will also include a roundtable discussion and a Q&A section to allow you to hear direct expert opinions from the speakers and contribute your own thoughts.

BioPharma Dealmakers webcasts are dedicated to small and large companies looking for commercial partnerships. Read the quarterly BioPharma Dealmakers supplement in Nature Biotechnology and Nature Reviews Drug Discovery.

Webcast sponsors retain sole responsibility for content.

Dr. Jeffrey Herz
President and CEO
Algomedix, Inc.
View Biography
Dr. Derek Chalmers
CEO, President, and Director
Cara Therapeutics, Inc.
View Biography
Dr. Jessica Preciado
Director of Product Development and Principal Scientist
View Biography
Dr. Steve Doberstein
Senior Vice President and Chief Scientific Officer
Nektar Therapeutics
View Biography
Moderator: Raveena Bhambra
BioPharma Dealmakers

Registration Details:

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

(*) denotes required form field(s)